相关实验视频

Updated: Jan 8, 2026

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

6.2K

介质素-2是一种强大的潜伏逆转剂,用于治疗HIV-1感染者

Michael L Freeman1,2,3, Brian M Clagett2, Konstantin Leskov1,4

  • 1Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.

Science advances
|December 19, 2025
PubMed
概括

复合性互白素-2 (rIL-2) 可以在接受抗逆转录病毒疗法 (ART) 的艾滋病毒感染者 (PWH) 中重新激活潜伏的HIV-1. 这种免疫激活可能有助于向艾滋病毒储存库以进行根除.

更多相关视频

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

16.2K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.8K

相关概念视频

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.1K